BALB/c mice |
Apoptosis and inflammation of liver tissue |
13 nm PEG-Coated AuNPs with the average injected numbers of particles per mice: 1.76 × 1011, 8.8 × 1011, and 4.4 × 1012 for low, middle, and high doses, respectively. |
[95,96] |
Broiler chicken |
Caused recognisable oxidative damage to blood, histopathological changes, up-regulation of IL-6, expression of Nrf2 gene, fragmentation of DNA, a significant decrease in antibody titer against avian influenza (AI) and Newcastle disease (ND) |
Gold nanoparticles colloidal solution (25 ± 5 nm) |
[97] |
D. magna
|
LC50 was reported as 2 mg/l after 48 h |
Nanoparticles with a diameter of approximately 15 nm |
[70] |
D. magna, T. arcticus
|
LC50 was reported as 0.64 mg/l after 48 h for D. magna and 14.4 mg/l after 96 h for T. arcticus
|
0–10 mg/L concentration of Au3+
|
[98] |
Drosophila melanogaster
|
Caused transmissible mutagenic effects |
Citrate-capped 15 nm AuNPs in the concentration of 100 pM |
[99] |
Drosophila melanogaster
|
Sharp decline in fertility and life span, presence of DNA fragments, and strong over-expression of stress proteins |
Citrate-capped 15 nm AuNPs in six different concentrations (1.9, 3.8, 19, 38, 190, and 380 pmol/L) dispersed in food |
[100] |
Female and male mice |
Liver and kidney damage whose effects were sex-dependent. Damage to the neuronal system |
Different diameters of AuNPs ranging from 3 to 100 nm |
[101] |
Female mice |
Spherical AuNPs in live and macrophages |
AuNPs of diameter 2, 4 and 100 nm in, respectively—15 × 1013 particles/mL, 9 × 1010/mL and the 100 nm 6 × 109/mL. |
[102] |
Fetal mouse organs |
No indication of toxicity in the fetus and placenta |
20 and 50 nm AuNPs |
[103] |
Male CD1 mice |
Accumulation at various parts of the brain |
Protein and polyelectroylte coated AuNPs with a diameter of 15 ± 1 nm injected in the concentration of 144.5 nM |
[104] |
Male Wistar rats |
AuNPs persist and accumulate in the spleen and liver |
AuNPs of 20 nm diameter were injected at 15.1 µg/mL. |
[11] |
Male WU Wistar rats |
Large particles of spherical AuNPs were observed in blood, spleen, and liver, while smaller particles were seen in the spleen, blood, thymus, lungs, liver, kidney, testis, heart, and brain |
Gold nanoparticles have a 10, 50, 100 and 250 nm diameter. Injection concentration was respectively 77, 96, 89 and 108 µg/mL |
[105] |
ICR Mice |
Lungs, kidney hemorrhage, lymphocytic infiltration, and inflammatory response |
PEGylated 13 nm gold colloids |
[87] |
Mice |
Liver damage |
5, 10, 30, and 60 nm PEG-coated AuNPS dosed 4000 µg/kg |
[106] |
Mice |
Apoptosis and acute inflammation |
13 nm PEG-coated AuNPs. The mean quantities of particles injected per mouse were 1.76 × 1011, 8.8 × 1011, and 4.4 × 1012 for the low, medium, and high doses, respectively. |
[96] |
Mice |
Affects kidney function and produces toxicity |
GSH- and BSA-coated AuNCs with an average size of 2.1 nm. The injected concentration is up to 7550 µg/mL |
[107] |
Mice |
Greatest toxicity and affecting organ index. Induced reduction in RBC, spleen index, and body weight |
Citrate-capped AuNPs of diameter 13.5 nm in different concentrations varying from 137.5 to 2200 µg/kg |
[93] |
Mice |
Produced no effect on normal growth |
AuNPs capped with BSA and HSePEGeCOOH in a diameter of about 4 nm in various concentrations |
[108] |
BALB/C Mice |
Caused loss of weight and appetite. However, smaller AuNPs did not produce any sickness |
Naked colloidal AuNPs ranging in diameter from 3 to 100 nm injected intraperitoneally at a dose of 8 mg/kg/week |
[5] |
Mice (ddy) |
AuNPs of all sizes were noticed in the spleen, liver, and lungs |
AuNPs ranging in size from 15 to 200 nm administered in 1 g/kg intravenously |
[109] |
Pregnant C57BL/6 mice |
Non-crossing of maternal-fetal barrier |
2 and 40 nm AuNPs injected intravenously and 40 nm intraperitoneally |
[110] |
Rats |
Accumulation in the spleen and liver |
PEG-coated AuNPsofdiameter ranging from 11 to 31 nm injected in various concentrations |
[111] |
Rats |
ROS-induced cytotoxicity that is size-dependent |
PEG-coated AuNPs in diameter ranging in size between 6.2 and 61.2 nm |
[112] |
Rats |
Distribution of AuNPs was observed in the testis, liver, and kidney. However, there were no effects on the testis, whereas mild changes were noticed in the kidney and liver sections |
AuNPs with an average size of 50 nm and various concentrations |
[113] |
Wistar rats |
Traces of AuNPs in the kidney, spleen, liver, intestine, urine, and feces. Smaller NPs induced greater effects on DNA damage |
AuNPs of 10, 30 or 60 nm diameter injected 0.4 mL/day |
[54] |
Wistar rats |
Accumulate in neurons, liver, spleen, kidney, and cross the blood-brain barrier; no toxicity |
12.5 nm citrate-coated AuNPs in different doses—40, 200 and 400 µg/kg/day |
[114] |
Zebrafish embryo |
Delay in the development of eyes and pigmentation |
1.3 nm AuNPs (functionalized with TMATeAuNPs)in concentrations ranging from 0.08 to 50 mg/L |
[7] |